+

WO1993004202A1 - Sondes de polynucleotide de detection de salmonelle - Google Patents

Sondes de polynucleotide de detection de salmonelle Download PDF

Info

Publication number
WO1993004202A1
WO1993004202A1 PCT/US1992/006984 US9206984W WO9304202A1 WO 1993004202 A1 WO1993004202 A1 WO 1993004202A1 US 9206984 W US9206984 W US 9206984W WO 9304202 A1 WO9304202 A1 WO 9304202A1
Authority
WO
WIPO (PCT)
Prior art keywords
salmonella
oligomer
gene
sequence
probe
Prior art date
Application number
PCT/US1992/006984
Other languages
English (en)
Inventor
Jorge Galan
Roy Curtiss, Iii
Original Assignee
Washington University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University filed Critical Washington University
Priority to EP92918989A priority Critical patent/EP0669989A1/fr
Publication of WO1993004202A1 publication Critical patent/WO1993004202A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Definitions

  • the present invention relates to methods and materials for identifying microorganisms. More
  • the instant invention pertains to methods for detecting Salmonella using polynucleotide probes and primers derived from the Salmonella typhimurium invA, B, C, and D genes. Background of the Invention
  • a key pathogenic mechanism of Salmonella is the organism's ability to invade the cells of the intestinal epithelium. Electron microscopic studies of Salmonella- infected laboratory animals (Takeuchi, A., Am J Pathol (1967) 50:109-136) and cultured cells (Finlay & Falkow, Mol Microbiol (1989) 3:1833-1841; Kohbata, S. et al., Microbiol Immunol (1986) 30:1225-1237) have shown that these organisms enter epithelial cells after transient disruption of the surface microvilli. Bacteria are later seen within endocytic vacuoles, in which, in some
  • Salmonella strains unlike other invasive bacteria, such as Shigella spp. (Bernardini, J.L., et al., Proc Natl Acad Sci USA (1989) 86:3867-3871; Makino, S., et al., Cell (1986) 46:551-555; Sansonetti, P., et al., Infect Immun (1986) 51:461-469) or Listeria spp.
  • Salmonella S. typhi, S. choleraesuis and S. enteritidis
  • serovars that infect a variety of different hosts
  • Hook, E.W. Principles and Practice of Infectious Diseases, 2nd ed., John Wiley and Sons, New York (1985)
  • Some species and serovars are host adapted (e.g., S.
  • invA, B, C, and D genes that allow S. typhimurium to enter cultured epithelial cells
  • the invA, B, and C genes are arranged in the same transcriptional unit, while the invD gene is located downstream in a different transcriptional unit.
  • Virulent strains of S. typhimurium carrying defined mutations in invA had higher 50% lethal doses than their parent strains when administered orally to mice and were deficient in their ability to colonize Peyer's patches and the small intestinal wall.
  • invA mutants were fully virulent when administered
  • inv genes are only needed for the display of virulence when S. typhimurium is administered by the natural route of entry (id.).
  • studies conducted with transcriptional and translational fusions of reporter genes to invA have established that the expression of the inv genes is regulated by changes in DNA supercoiling as a consequence of a variety of environmental signals, such as
  • polynucleotide sequences present in the Salmonella typhimurium inv genes can be used as universal probes or primers for the detection of almost any Salmonella species, strain or serotype. These sequences are specific for Salmonella and do not react with other closely related enteric bacteria. As such, these sequences can serve as
  • the subject invention is directed to an oligomer capable of
  • the oligomer comprises at least 8 contiguous nucleotides derived from a Salmonella
  • the present invention is directed to a method for detecting the presence or absence of a Salmonella polynucleotide sequence in an analyte strand.
  • the method comprises:
  • Salmonella typhimurium inv gene Salmonella typhimurium inv gene
  • the method uses a set of oligomers which are primers for the polymerase chain reaction method and which flank the target region.
  • the target region is amplified via the polymerase chain reaction.
  • the subject invention is directed to a kit for detecting the presence or absence of a Salmonella polynucleotide sequence in an analyte strand.
  • the kit comprises an oligomer as
  • the oligomer is derived from the invA, B, C, and/or D genes, or the invABC operon.
  • Figure 1 depicts the nucleotide sequence of the invA gene of S. typhimurium.
  • Figure 2 shows the restriction maps for the recombinant plasmids from which DNA probes were derived.
  • Figure 2A shows the restriction map for plasmid pYA2220.
  • Figure 2B shows the restriction map for plasmid pYA2219.
  • the positions of the invABC genes and the direction of transcription are indicated by horizontal arrows.
  • the position of the invD gene is indicated by the heavy line underneath pYA2219 and is contained within the 2.4-kb EcoRI fragment of pYA2219.
  • the region shown by the heavy line was determined by TnphoA mutagenesis (Galan &
  • Salmonella any bacterium either currently classified or later identified in the genus Salmonella.
  • the salmonellae are motile rods that characteristically ferment glucose and mannose without producing gas but do not ferment lactose or sucrose.
  • the group includes three primary species, S. typhi, S.
  • S. typhimurium inv gene any of the group of genes found in S. typhimurium which is responsible for the ability of S. typhimurium to enter cultured epithelial cells as determined by conventional assays, including the tissue culture cell assay described in the examples. At least four genes have been found to be involved in the invasive phenotype - - invA, invB, invC and invD. In some instances, as depicted in Figure 2, the invA, B and C genes are arranged in the same transcriptional unit (called the “invABC operon” herein) and invD is located downstream of this cluster in an independent transcriptional unit.
  • invABC operon the same transcriptional unit
  • nucleotide seqence "derived from" a designated sequence refers to a nucleotide sequence capable of specifically hybridizing to a
  • Salmonella sequence and which is comprised of a sequence of approximately at least about 8 nucleotides, preferably at least about 10-12 nucleotides, more preferably at least about 15-20 nucleotides corresponding to a region of the designated nucleotide sequence. "Corresponding" means homologous to or complementary to the designated sequence. Hybridization techniques for determining the complementarity of nucleic acid sequences are known in the art, and are discussed infra. In addition,
  • hybridization can be determined by known techniques, including for example, digestion with a nuclease such as SI that specifically digests single-stranded areas in duplex polynucleotides.
  • Regions from which typical DNA sequences of the subject invention may be "derived" include any of the S. typhimurium inv genes, including but not limited to the invA, B, or C genes, either individually or as a transcriptional unit, and/or the invD gene.
  • the derived nucleotide sequence is not necessarily physically derived from the nucleotide sequence shown, but may be generated in any manner, including for example, chemical synthesis or DNA
  • polynucleotide intends a polynucleotide of genomic, cDNA, semisynthetic, or synthetic origin which, by virtue of its origin or manipulation: (1) is not associated with all or a portion of a polynucleotide with which it is associated in nature, (2) is linked to a polynucleotide other than that to which it is linked in nature, (3) does not occur in nature, or (4) is not in the form of a library.
  • polynucleotide refers to a polymeric form of nucleotides of any length, either ribonucleotides or deoxyribonucleotides. This term refers only to the primary structure of the molecule. Thus, this term includes double- and single-stranded DNA and RNA. It also includes known types of modifications, for example, labels which are known in the art,
  • intemucleotide modifications such as, for example, those with uncharged linkages (e.g., methyl phosphonates, phosphotriesters, phosphoamidates, carbamates, etc.) and with charged linkages (e.g., phosphorothioates,
  • phosphorodithioates those containing pendant moieties, such as, for example proteins (including e.g., nucleases, toxins, antibodies, signal peptides,
  • poly-L-lysine, etc. those with intercalators (e.g., acridine, psoralen, etc.), those containing chelators (e.g., metals, radioactive metals, boron, oxidative metals, etc.), those containing alkylators, those with modified linkages (e.g., alpha anomeric nucleic acids, etc.), as well as unmodified forms of the polynucleotide.
  • intercalators e.g., acridine, psoralen, etc.
  • chelators e.g., metals, radioactive metals, boron, oxidative metals, etc.
  • alkylators those with modified linkages (e.g., alpha anomeric nucleic acids, etc.), as well as unmodified forms of the polynucleotide.
  • the "sense strand" of a nucleic acid contains the sequence that has sequence homology to that of mRNA.
  • the "anti-sense strand” contains a sequence which is complementary to that of the “sense strand”.
  • primer refers to an oligomer which is capable of acting as a point of initiation of synthesis of a polynucleotide strand when placed under appropriate conditions.
  • the primer will be
  • the primer will anneal to the complementary region of the analyte strand.
  • suitable reactants e.g., a polymerase, nucleotide triphosphates, and the like
  • the primer is extended by the polymerizing agent to form a copy of the analyte strand.
  • the primer may be single-stranded, or alternatively may be partially or fully double-stranded.
  • analyte polynucleotide and “analyte strand” refer to a single- or double-stranded nucleic acid molecule which is suspected of containing a target sequence, and which may be present in a biological sample.
  • oligomer refers to primers and to probes.
  • the term oligomer does not connote the size of the molecule.
  • An oligomer may comprise an entire transcript. Alternatively, an
  • oligomer may comprise only part of a gene. If so, the oligomer will generally be no greater than 1000
  • nucleotides are typically no greater than 500
  • nucleotides even more typically no greater than 250 nucleotides; it may be no greater than 100 nucleotides, and may be no greater than 75 nucleotides, and also may be no greater than 50 nucleotides in length.
  • probe refers to a structure comprised of a polynucleotide which forms a hybrid structure with a target sequence, due to
  • probes may be composed of DNA, and/or RNA, and/or synthetic nucleotide analogs.
  • the probe does not contain a sequence complementairy to sequence (s) used to prime the polymerase chain reaction (PCR) .
  • target region refers to a region of the nucleic acid which is to be amplified and/or detected.
  • target sequence refers to a sequence with which a probe or primer will form a stable hybrid under desired conditions.
  • targeting polynucleotide sequence refers to a polynucleotide sequence which is comprised of nucleotides which are complementary to a target nucleotide sequence; the sequence is of sufficient length and complementarity with the target sequence to form a duplex which has sufficient stability for the purpose intended.
  • Coupled refers to attachment by covalent bonds or by strong non-covalent interactions (e.g., hydrophobic interactions, hydrogen bonds, etc.). Covalent bonds may be, for example, ester, ether, phosphoester, amide, peptide, imide, carbon-sulfur bonds, carbon-phosphorus bonds, and the like.
  • support refers to any solid or semi-solid surface to which a desired binding partner may be anchored. Suitable supports include glass, plastic, metal, polymer gels, and the like, and may take the form of beads, wells, dipstics, membranes, and the like.
  • label refers to any atom or moiety which can be used to provide a detectable (preferably quantifiable) signal, and which can be attached to a polynucleotide or polypeptide.
  • label probe refers to an oligomer which is comprised of a targeting polynucleotide sequence, which is complementary to a target sequence to be detected in the analyte
  • This complementary region is of
  • the oligomer is coupled to a label either
  • Sets of ligand molecules with high specificity are known in the art and include for example biotin and avidin or streptavidin, IgG and protein A, other numerous known receptor-ligand couples, and complementary polynucleotide strands.
  • a "biological sample” refers to a sample of tissue or fluid isolated from a vertebrate subject, including but not limited to, for example, blood, plasma, serum, stool, urine, bone marrow, bile, spinal fluid, lymph fluid, the external sections of the skin, respiratory, intestinal, and genitourinary tracts, tears, saliva, milk, blood cells, organs, and also samples of in vitro cell culture constituents (including but not limited to conditioned medium resulting from the growth of cells in cell culture medium, putatively
  • Salmonella infected cells Salmonella infected cells, recombinant cells, and cell components).
  • the present invention is based on the discovery that the S. typhimurium inv genes can be used as the S. typhimurium inv genes.
  • invA, invB, invC, and invD have been isolated and the invA gene sequenced ( Figure 1).
  • the invA, B, and C genes occur as a single transcriptional unit with the invD gene found downstream of this operon.
  • the genes are unique to the salmonellae, and as such, provide an eloquent means for detecting the presence of any Salmonella organism in a biological sample.
  • oligomers can be constructed which are useful as reagents for detecting Salmonella polynucleotides in biological samples.
  • DNA oligomers of about 8-10 nucleotides or larger, can be synthesized using standard techniques. These oligomers, in turn, can be used as hybridization probes and amplification primers to detect the presence or absence of Salmonella DNA in, for
  • novel oligomers described herein also enable further characterization of the Salmonella genome as well as the elucidation of the mode of invasion of these organisms.
  • the oligomers can also be used for identifying new Salmonella strains and serotypes. Since the described probes and primers are specific for
  • Salmonella genus can be tested for their ability to hybridize with these oligomers. If hybridization occurs, these bacteria can be further characterized. Oligomer Probes and Primers
  • oligomers of approximately 8 nucleotides or more can be prepared which specifically hybridize with Salmonella target sequences. These oligomers can serve as probes for the detection
  • oligomers contain a targeting polynucleotide sequence (as defined above), which is comprised of nucleotides which are complementary to a target Salmonella nucleotide sequence.
  • the sequence is of sufficient length and complementarity with the
  • the oligomers should include a polynucleotide region of adequate length and complementarity such that the analyte can be immobilized on a solid surface under the isolation conditions.
  • the oligomers are to serve as primers for the transcription and/or replication of target Salmonella sequences in an analyte polynucleotide, they should contain a polynucleotide region of sufficient length and complementarity to the targeted Salmonella sequence to allow the polymerizing agent to continue replication from the primers which are in stable duplex form with the target sequence, under the polymerizing conditions.
  • the oligomers may contain a minimum of about
  • 4-6 contiguous nucleotides which are complementary to the targeted Salmonella sequence usually a minimum of about 8 continguous nucleotides, and preferably a minimum of about 14 contiguous nucleotides which are complementary to the targeted Salmonella sequence. However, a minimum of about 20 nucleotides or more appears optimal.
  • Suitable Salmonella nucleotide targeting sequences may be comprised of contiguous sequences of nucleotides from any of the inv genes including invA, invB, invC, and invD. As explained above, the sequences used need not represent the complete gene, so long as they are of sufficient length to hybridize to a
  • Salmonella target sequence Particularly useful are probes derived from the invA gene sequence depicted in Figure 1. It has been found, using polymerase chain reaction (PCR) technology, that primers from this sequence are able to specifically amplify Salmonella gene sequences from hundreds of strains of the organism while failing to react with other closely related enteric bacteria.
  • Other particularly suitable sequences include those derived from the invABC operon. Such sequences can include all of the operon, such as probe 2 in Figure 2A, or truncated forms of the same, such as probe 1 in Figure 2A. Again, such probes have been found to be highly specific for the salmonellae.
  • probes derived from the invD gene such as probe 3 of Figure 2B herein.
  • probes derived from the invD gene such as probe 3 of Figure 2B herein.
  • the oligomer may contain, in addition to the target sequences, nucleotide sequences or other moieties.
  • the oligomers may include sequences which, when in duplex, form restriction enzyme sites which facilitate the cloning of the
  • the preparation of the oligomers is by routine methods, including, for example, excision, transcription, or chemical synthesis.
  • the speciman to be analyzed may be treated, if desired, to extract the nucleic acids contained therein.
  • the resulting nucleic acid from the sample is subjected to gel electrophoresis or other size separation techniques.
  • the nucleic acid sample may be dot blotted without size separation.
  • the targeted region of the analyte nucleic acid In order to form hybrid duplexes with the targeting sequence of the probe, the targeted region of the analyte nucleic acid must be in single stranded form. Denaturation can be carried out by various techniques known in the art. Subsequent to denaturation, the analyte nucleic acid and probe are incubated under conditions which promote stable hybrid formation of the target sequence in the probe with the putative targeted sequence in the analyte, and the resulting duplexes containing the probe (s) are detected.
  • Detection of the resulting duplex is usually accomplished by the use of labeled probes.
  • the probe may be unlabeled, but may be detectable by specific binding with a ligand which is labeled, either directly or indirectly.
  • Suitable labels, and methods for labeling probes and ligands are known in the art, and include, for example, radioactive labels which may be incorporated by known methods (e.g., nick translation or kinasing), biotin, fluorescent groups, chemiluminescent groups (e.g., dioxetanes, particularly triggered dioxetanes), enzymes, antibodies, and the like.
  • the region of the probes which are used to bind to the analyte can be made completely complementary to an inv gene. Therefore, high stringency conditions can be used in order to prevent false positives.
  • the stringency of hybridization is determined by a number of factors during hybridization and during the washing procedure, including temperature, ionic strength, length of time, and concentration of formamide. These factors are outlined in, for example, Sambrook et al. (1989).
  • detecting Salmonella in these assays are comprised of sequences which hybridize with target Salmonella
  • duplexes polynucleotide sequences to form duplexes with the analyte strand, wherein the duplexes are of sufficient stability for detection in the specified assay system.
  • a suitable variation is, for example, one which is described in U.S. Patent No. 4,868,105, issued Sept. 9, 1989, and in EPO Publication No. 225,807 (published June 16, 1987). These publications describe a solution phase nucleic acid hybridization assay in which the analyte nucleic acid is hybridized to a labeling probe set and to a capturing probe set. The probe-analyte complex is coupled by hybridization with a
  • the labeling probe set is complementary to a labeled probe that is bound through hybridization to the solid phase/analyte complex.
  • Salmonella inv sequences will be present in serum of infected subjects at relatively low levels. Accordingly, amplification techniques may be used in the hybridization assays in order to increase the sensitivity thereof.
  • PCT Publication 84/03520 and EP Publication No. 124221 describe a DNA hybridization assay in which: (1) analyte is annealed to a single-stranded DNA probe that is complementary to an enzyme-labeled oligonucleotide; and (2) the resulting tailed duplex is hybridized to an enzyme-labeled
  • hybridization assay in which analyte DNA is contacted with a probe that has a tail, such as a poly-dT tail, an amplifier strand that has a sequence that hybridizes to the tail of the probe, such as a poly-A sequence, and which is capable of binding a plurality of labeled strands.
  • a probe that has a tail such as a poly-dT tail
  • an amplifier strand that has a sequence that hybridizes to the tail of the probe, such as a poly-A sequence, and which is capable of binding a plurality of labeled strands.
  • a particularly desirable technique for the detection of Salmonella using polynucleotides derived from the inv genes involves amplification of the target Salmonella sequences using the polymerase chain reaction (PCR) technique described by Saiki et al. (1986), by Mullis, U.S. Patent No. 4,683,195, and by Mullis et al. U.S. Patent No. 4,683,202, the disclosures of which are incorporated herein by reference in their entirety.
  • PCR polymerase chain reaction
  • Amplification may be prior to, or preferably subsequent to, purification of the Salmonella target sequence.
  • Amplification may be utilized in conjunction with the assay methods described above.
  • the PCR method uses primers and probes derived from the information provided herein concerning the Salmonella inv genes.
  • short oligonucleotide primers are prepared which match opposite ends of a desired sequence.
  • the sequence between the primers need not be known.
  • a sample of polynucleotide is extracted and denatured. Strand separation may be accomplished by any suitable denaturing method, including physical, chemical, or enzymatic means, which are known to those of skill in the art.
  • a commonly used method, which is physical, involves heating the nucleic acid until it is completely (>99%) denatured. Typical heat denaturation involves temperatures ranging from about 80°C to about 105°C, for times ranging from about 1 to 10 minutes
  • oligonucleotide primers which are present in molar excess.
  • Polymerization is catalyzed by a template- and primer-dependent polymerase in the presence of deoxynucleotide triphosphates or nucleotide analogs (dNTPs).
  • dNTPs deoxynucleotide triphosphates or nucleotide analogs
  • the second cycle provides the two original strands, the two long products from cycle 1, and two "short products" replicated from the long products.
  • the short products contain sequences (sense or antisense) derived from the target sequence, flanked at the 5'- and 3' -termini with primer sequences.
  • the number of short products is replicated exponentially. Thus, this process causes the amplification of a specific target sequence.
  • the primers are selected so that their relative positions along a duplex sequence are such that an extension product synthesized from one primer, when it is separated from its template (complement), serves as a template for the extension of the other primer to yield a replicate chain of defined length.
  • the primer is preferably single stranded for maximum efficiency in amplification, but may
  • the primer is first treated to separate its strands before being used to prepare extension products.
  • the primer is an oligodeoxyribonucleotide.
  • the primer must be sufficiently long to prime the
  • the oligonucleotide primer typically contains about 15-45 nucleotides, although it may contain more or fewer nucleotides. Short primer molecules generally require cooler temperatures to form sufficiently stable hybrid complexes with the template.
  • primers used herein are selected to be “substantially" complementary to the different strands of each specific sequence to be amplified. Therefore, the primers need not reflect the exact sequence of the template, but must be sufficiently complementary to selectively hybridize with their respective strands. For example, a non-complementary nucleotide fragment may be attached to the 5' -end of the primer, with the remainder of the primer sequence being complementary to the strand. Alternatively, non-complementary bases or longer
  • sequences can be interspersed into the primer, provided that the primer has sufficient complementarity with the sequence of one of the strands to be amplified to
  • the non- complementary nucleotide sequences of the primers may include restriction enzyme sites. Appending a restriction enzyme site to the end(s) of the target sequence would be particularly helpful for cloning of the target sequence.
  • primer may refer to more than one primer, particularly in the case where there is some ambiguity in the
  • primer oligonucleotides in this collection will be homologous with the end of the target sequence.
  • amplification of Salmonella inv sequences are those derived from the invA gene depicted in Figure 1.
  • a set of primers based on the invA gene sequence and used in the PCR technique is described in the examples herein. These primers specifically amplified 99.4% of the 636 Salmonella strains tested and failed to react with other non-Salmonella strains.
  • One skilled in the art can easily devise other primers for use in the PCR method by reference to the instant disclosure.
  • the oligonucleotide primers may be prepared by any suitable method. Methods for preparing
  • oligonucleotides of a specific sequence are known in the art, and include, for example, cloning and restriction of appropriate sequences, and direct chemical synthesis.
  • Chemical synthesis methods may include, for example, the phosphotriester method described by Narang et al. (1979), the phosphodiester method disclosed by Brown et al.
  • the primers may be labeled, if desired, by incorporating means detectable by spectroscopic, photochemical, biochemical, immunochemical, or chemical means.
  • oligonucleotide primer (s) is catalyzed by a polymerizing agent in the presence of adequate amounts of the four deoxyribonucleotide triphosphates (dATP, dGTP, dCTP and dTTP) or analogs, in a reaction medium which is comprised of the appropriate salts, metal cations, and pH buffering system.
  • Suitable polymerizing agents are enzymes known to catalyze primer- and template-dependent DNA synthesis.
  • Known DNA poiymerases include, for example, E. coli DNA polymerase I or its Klenow fragment, T. DNA polymerase, and Taq DNA polymerase. The reaction conditions for catalyzing DNA synthesis with these DNA poiymerases are known in the art.
  • the products of the synthesis are duplex molecules consisting of the template strands and the primer extension strands, which include the target sequence. These products, in turn, serve as template for another round of replication.
  • the primer extension strand of the first cycle is annealed with its complementary primer.
  • Synthesis yields a "short" product which is bounded on both the 5'- and the 3'-ends by primer sequences or their complements. Repeated cycles of denaturation, primer annealing, and extension result in the exponential accumulation of the target region defined by the primers. Sufficient cycles are run to achieve the desired amount of polynucleotide containing the target region of nucleic acid. The desired amount may vary, and is determined by the function which the product polynucleotide is to serve.
  • the PCR method can be performed in a number of temporal sequences. For example, it can be performed step-wise, where after each step new reagents are added, or in a fashion where all of the reagents are added simultaneously, or in a partial step-wise fashion, where fresh reagents are added after a given number of steps.
  • the PCR reaction is carried out as an automated process which utilizes a
  • thermostable enzyme In this process the reaction mixture is cycled through a denaturing region, a primer annealing region, and a reaction region.
  • a machine may be employed which is specifically adapted for use with a thermostable enzyme, which utilizes temperature cycling without a liquid handling system, since the enzyme need not be added at every cycle.
  • the target polynucleotides are detected by hybridization with a probe polynucleotide which forms a stable hybrid with that of the target sequence under stringent to moderately stringent hybridization and wash conditions. If it is expected that the probes will be completely complementary (i.e., about 99% or greater) to the target sequence, stringent conditions can be used. If some mismatching is expected, the stringency of hybridization may be
  • incubation/wash temperature and moderately stringent conditions are those where incubation occurs in solutions which contain approximately 1-2 X SSC, 0.1% SDS and about 50°-65°C incubation/wash temperature.
  • Low stringency conditions are 2 X SSC and about 30°-50°C.
  • Probes for use in the hybridization reaction may be derived from the Salmonella inv genes as described above.
  • the probes may be of any suitable length which span the target region, but which exclude the primers, and which allow specific hybridization to the target region. If there is to be complete complementarity, i.e., if the strain contains a sequence identical to that of the probe, since the duplex will be relatively stable even under stringent conditions, the probes may be short, i.e., in the range of about 10-30 base pairs. If some degree of mismatch is expected with the probe, the probe may be of greater length, since length seems to
  • the probe nucleic acid having a sequence complementary to the target sequence may be synthesized using similar techniques described above for the
  • the probe may be labeled. Appropriate labels are also described above.
  • the presence of the target sequence in a biological sample is detected by determining whether a hybrid has been formed between the Salmonella
  • polynucleotide probe and the nucleic acid subjected to the PCR amplification technique.
  • Methods to detect hybrids formed between a probe and a nucleic acid sequence are known in the art. For example, for
  • an unlabeled sample may be transferred to a solid matrix to which it binds, and the bound sample subjected to conditions which allow specific
  • the solid matrix is than examined for the presence of the labeled probe.
  • the unlabeled probe is bound to the matrix, and after the exposure to the appropriate hybridization conditions, the matrix is examined for the presence of label .
  • suitable hybridization assays are described supra.
  • S. typhimurium strain DB4673 is an isolate of TS736 (Palva & Liljeström, Mol Gen Genet
  • E. coli strains CC118 Manoil & Beckwith, Proc Natl Acad Sci USA (1985) 82:8129-8133
  • JC7623 Winans, S.C., et al., J Bacteriol (1985) 121:1219-1221
  • ⁇ 2819 Jacobs, W.R., et al., Infect Immun (1986) 52:101-109 have also been described.
  • Bacteria were grown in L broth or on L agar plates
  • Plasmid DNA was isolated by the method of Birnboim, H.C., and Doly, J., Nucleic Acids Res (1979) 7:1513-1523. Total cell DNA was isolated as follows. Bacterial strains were grown overnight in L broth at 37°C in a rotating wheel.
  • DNA probes were prepared as follows. Plasmid DNA was digested with the appropriate enzymes, and DNA fragments were separated by electrophoresis on a 0.7% agarose gel. The DNA fragments of interest were isolated with
  • Membranes were washed two times for 5 min each time in 2x SSC (1x SSC is 150 mM sodium chloride-15 mM sodium citrate) at room temperature, two times for 30 min each time in 2x SSC-1% SDS at 65°C, and two times for 30 min each time in 0.1x SSC at room temperature.
  • 2x SSC 1x SSC is 150 mM sodium chloride-15 mM sodium citrate
  • hybridization were carried out under similar conditions, except that 20% formamide was used and washes were performed at 55°C in buffer containing 0.1% SDS.
  • Membranes were air dried and exposed to X-Omat AR film (Eastman Kodak Co., Rochester, N.Y.). Membranes were reused after being washed with 0.4 N sodium hydroxide at 42°C for 2 to 5 h and with 0.1x SSC-0.1% SDS-0.2 M Tris- HC1 (pH 7.5) at 42°C for 2 h. Washed blots were exposed to X-Omat AR film to verify successful washing. Colony blots were prepared as described elsewhere (Maniatis, T., et al., Molecular Cloning: A Laboratory Manual (1982), Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.) and hybridized as described above.
  • Salmonella Strains A total of 91 Salmonella strains (Table 2) were tested for their ability to invade cultured Henle-407 cells. All strains were clinical isolates from humans and a variety of other animal species. These isolates represent the species S. typhi, S. choleraesuis. and S. enteritidis and a large number of serovars belonging to a variety of O-antigenic types.
  • invABC genes were originally cloned from S. typhimurium SR-11 as described (Galan & Curtiss, Proc
  • the library was transduced into ⁇ 2819, in vivo packed as described (Jacobs, W.R., et al., Infect Immun (1986) 52:101-109), and stored as a lysate over
  • strain DB4673 although unable to penetrate Henle-407 cells, was able to adhere to these cells at levels equivalent to those of a wild-type strain.
  • Strain DB4673 was, therefore, used as a recipient for a S. typhimurium SR-11 DNA library in the cosmid vector pREG153, to isolate genes that rendered DB4673 capable of invading monolayers of Henle-407 cells.
  • a cosmid clone (pYA2217) was isolated which conferred on DB4673 the ability to penetrate Henle-407 cells as efficiently as its wild-type progenitor.
  • Insertion inv- 61 and three other similar insertions that completely abolished the invasive phenotype, yielded productive fusions to alkaline phosphatase indicating that these insertions most likely resided within the structural gene of a secreted protein (Manoil & Beckwith, Proc Natl Acad Sci USA (1985) 82:8129-8133).
  • Plasmid-encoded polypeptides were analyzed in a DNA-directed in vitro transcription/translation system.
  • the pYA2219 insert DNA encoded at least six proteins (in addition to those encoded by the vector pACYC184) with the following molecular masses: 86, 64 (sometimes migrating as a doublet), 54, 47, 33, and 30 kDa were specified by TnphoA and both corresponded to similar size proteins encoded by pYA2219.
  • Proteins encoded by a pYA2219inv-61: :TnphoA insert generated a productive alkaline phosphatase fusion, inactivated the expression of the 64-, 54-, and 47-kDA polypeptides and generated a new protein of 50 kDa, a product of the fusion of
  • x67: :TnphoA, x68: :TnphoA, and x21: :TnphoA did not affect the expression of any proteins encoded by pYA2219 and did not affect the invasive phenotype.
  • pACYC184 :TnphoA encoded 54- and 33-kDa proteins that comigrated with two proteins encoded by pYA2219, preventing the unambiguous interpretation of the protein data.
  • pYA2219 a series of overlapping deletions of pYA2219 were constructed by subcloning sequences from pYA2219 into pUC18 and were subjected to in vitro transcription/translation analysis.
  • pYA2220 ( Figure 2A) contains the leftmost end of the 18-kb insert DNA of pYA2219 from the Hindlll to the closest PstI site and encodes three proteins of 64, 54, and 47 kDA in addition to those of pUC18.
  • invA, invB, and invC are in the same transcriptional unit ( Figure 2).
  • Example 2 To determine whether the invABC genes cloned in Example 2 were present in other Salmonella species and serovars and thus would be useful as probes for
  • Salmonella, colony blot hybridization analysis was performed on 91 Salmonella strains (Table 2).
  • the probe used was a 3.4-kb Clal-EcoRI fragment of pYA2220 (probe 1; Figure 2A) that contains most of the invABC operon, with no flanking sequences, as determined by preliminary sequence analysis. All Salmonella strains tested hybridized to the probe under high-stringency conditions (see Materials and Methods). No qualitative difference between the intensities of the signals of the positive control strain (S. typhimurium SR-11) and the other
  • Salmonella strains was detected. The results indicate that these genes are not only present in all or most salmonellae but are also highly conserved.
  • invABC operon The 2.6-kb EcoRI-PvuII and 1.1-kb PvuII- PvuII fragments internal to the invABC operon were conserved in all strains tested, except for S. arizonae strains, which showed a single high-molecular-weight hybridizing fragment. Some polymorphisms were observed in the restriction fragment containing sequences flanking the invABC genes.
  • the invD locus was originally identified by transposon insertional mutagenesis of pYA2219, a plasmid that contains DNA from S. typhimurium SR-11 and was able to complement an invasion-deficient strain of S. typhimurium (Galan & Curtiss, Proc Natl Acad Sci USA (1989) 22:6383-6387).
  • Transposon insertions in the invD locus diminished, but did not abolish, the complementing ability of pYA2219 and also eliminated the expression of a 30-kDa polypeptide in an in vitro
  • probe 3 has sequences that flank invD, since some transposon insertions in pYA2219 that mapped near one end of the 2.4-kb EcoRI fragment did not affect the complementing ability of this plasmid and therefore are assumed to be outside invD. In addition, probe 3 contains more DNA than would be needed to encode a 30-kDa polypeptide, the product of inyD.
  • Salmonella species and serovars are useful as an agent to detect the same.
  • invA mutants (unable to express the invABC genes) of S. typhi. S. gallinarum. S. dublin, and S. enteritidis were constructed by transducing these strains to kanamycin resistance with a P22HTint lysate prepared on strain SB103.
  • SB103 is an S. typhimurium strain that carries an insertion of a kanamycin
  • a Invasion is expressed as the percentage of the initial inoculum of bacteria that was insensitive to gentamicin because of cell invasion. The values represent the averages ⁇ standard deviations for three samples, Similar results were obtained in several repetitions of this experiment.
  • Taq polymerase was used. See, e.g. U.S. Patent No. 4,683,195 and 4,683,202 and Saiki, R.K., et al.,
  • enteric bacteria other than Salmonella strains have been shown to invade cultured epithelial cells (Miller, V.L., et al., Curr Top Microbiol Immunol (1988) 138:15-39; Small, H., Infect Immun (1987) 55:1674- 1679). Accordingly, several of these strains, including Yersinia spp., Shigella spp., and enteroinvasive and enteropathogenic E. coli, were tested for DNA sequences similar to invABC or invD. The 3.4-kb Clal-EcoRI
  • Salmonella in biological samples are disclosed as well as probes and primers for use in the same.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des sondes de polynucléotides et des agents d'amorçage dérivés de gènes de Salmonella typhimurium inv. Ces polynucléotides peuvent être utilisés comme sondes universelles et comme amorces pour détecter la présence ou l'absence de séquences de nucléotides de Salmonella dans un échantillon biologique.
PCT/US1992/006984 1991-08-22 1992-08-19 Sondes de polynucleotide de detection de salmonelle WO1993004202A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP92918989A EP0669989A1 (fr) 1991-08-22 1992-08-19 Sondes de polynucleotide de detection de salmonelle

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74944791A 1991-08-22 1991-08-22
US749,447 1991-08-22

Publications (1)

Publication Number Publication Date
WO1993004202A1 true WO1993004202A1 (fr) 1993-03-04

Family

ID=25013802

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/006984 WO1993004202A1 (fr) 1991-08-22 1992-08-19 Sondes de polynucleotide de detection de salmonelle

Country Status (3)

Country Link
EP (1) EP0669989A1 (fr)
AU (1) AU2509592A (fr)
WO (1) WO1993004202A1 (fr)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029261A1 (fr) * 1994-04-25 1995-11-02 University Of Hawaii Detection et identification d'agents pathogenes intestinaux
WO1995033854A1 (fr) * 1994-06-06 1995-12-14 E.I. Du Pont De Nemours And Company Utilisation d'un marqueur specifique pour detecter la salmonella avec pcr
EP0721989A1 (fr) * 1995-01-16 1996-07-17 Institut Pasteur Oligonucléotides pour la détection de salmonella
WO1996017951A3 (fr) * 1994-12-09 1996-10-17 Rpms Technology Ltd Identification de genes responsables de la survie de microorganismes in vivo
US5635617A (en) * 1993-04-26 1997-06-03 University Of Victoria Innovation & Development Corp. Methods and compositions comprising the agfA gene for detection of Salmonella
EP0739987A3 (fr) * 1995-04-28 1998-07-29 Shimadzu Corporation Oligonucléotides et procédé pour le dépistage de Salmonella
US5846783A (en) * 1996-01-16 1998-12-08 Gull Laboratories Methods and apparatus for preparing, amplifying, and discriminating multiple analytes
WO2000002913A1 (fr) * 1998-07-10 2000-01-20 Jari Pharmaceuticals B.V. Proteine du staphylocoque inhibitrice de chimiotactisme et son utilisation
FR2809105A1 (fr) * 2000-05-18 2001-11-23 Becton Dickinson Co Amorces d'amplification modifiees et leurs utilisations
WO2003076641A3 (fr) * 2002-03-11 2003-12-04 Univ Sevilla Procede de detection et d'identification rapide de bacteries pathogenes transmissibles par des aliments au moyen de l'amplification en chaine par polymerase en temps reel
US6936425B1 (en) 1998-09-04 2005-08-30 Microscience Limited Attenuated salmonella SP12 mutants as antigen carriers
US7081513B2 (en) 2000-01-07 2006-07-25 Alligator Bioscience Ab Nucleic acids encoding (poly) peptides having chips activity
US7887816B2 (en) 1999-05-10 2011-02-15 Emergent Product Development Uk Limited Attenuated microorganisms for the treatment of infection
EP2284283A1 (fr) * 2008-04-30 2011-02-16 Universidad del Pais Vasco Procédés et réactifs pour la détection de salmonella sp.
US8445254B2 (en) 2007-05-10 2013-05-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
US8465755B2 (en) 2007-10-05 2013-06-18 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
US8889121B2 (en) 2010-01-22 2014-11-18 The Arizona Board Of Regents For An On Behalf Of Arizona State University Bacterium comprising a regulated rfaH nucleic acid
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9050285B2 (en) 2008-10-17 2015-06-09 The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9481888B2 (en) 2009-05-22 2016-11-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
KR101793682B1 (ko) * 2010-03-11 2017-11-03 한화테크윈 주식회사 절단 가능한 키메릭 프로브를 사용한 살모넬라의 실시간 검출 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355989A2 (fr) * 1988-07-29 1990-02-28 Shimadzu Corporation Sondes d'ADN et d'ARN, méthodes et trousses pour détecter la salmonelle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2009708A1 (fr) * 1989-02-13 1990-08-13 Jane D. Madonna Sonde d'acide nucleique pour la detection des salmonella pathogene pour les humains
NL8900670A (nl) * 1989-03-17 1990-10-16 Stichting Tech Wetenschapp Polynucleotide-probe, werkwijze en kit voor het identificeren en opsporen van gram-negatieve bacterien.
DE69032778T2 (de) * 1989-07-18 1999-07-29 Shimadzu Corp., Kyoto Verfahren zur Untersuchung von durch Mikroorganismen verursachten Lebensmittelvergiftungen und Reagens dafür

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355989A2 (fr) * 1988-07-29 1990-02-28 Shimadzu Corporation Sondes d'ADN et d'ARN, méthodes et trousses pour détecter la salmonelle

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Bio/Technology, Volume 8, issued March 1990, T. BARRY et al., "A General Method to Generate DNA Probes for Microorganisms", pages 233-236, especially pages 233 and 234. *
Proceedings National Academy of Sciences, USA, Volume 86, issued August 1989, J.E. GALAN et al., "Cloning and Molecular Characterization of Genes Whose Products allow Salmonella Typhimurium to Penetrate Tissue Culture Cells", pages 6383-6387, especially pages 6384 and 6385. *
See also references of EP0669989A4 *

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635617A (en) * 1993-04-26 1997-06-03 University Of Victoria Innovation & Development Corp. Methods and compositions comprising the agfA gene for detection of Salmonella
US5627275A (en) * 1994-04-25 1997-05-06 University Of Hawaii Detection and identification of enteric pathogens
WO1995029261A1 (fr) * 1994-04-25 1995-11-02 University Of Hawaii Detection et identification d'agents pathogenes intestinaux
US5705332A (en) * 1994-04-25 1998-01-06 University Of Hawaii Detection and identification of Salmonella and Shigella
WO1995033854A1 (fr) * 1994-06-06 1995-12-14 E.I. Du Pont De Nemours And Company Utilisation d'un marqueur specifique pour detecter la salmonella avec pcr
WO1996017951A3 (fr) * 1994-12-09 1996-10-17 Rpms Technology Ltd Identification de genes responsables de la survie de microorganismes in vivo
US6342215B1 (en) 1994-12-09 2002-01-29 Imperial College Innovations Limited Identification of genes
CZ296981B6 (cs) * 1994-12-09 2006-08-16 Imperial College Innovations Limited Zpusob pro identifikaci mikroorganizmu, zpusob identifikování genu, mikroorganizmus, vakcína a zpusob její prípravy, zpusob získání mutantního mikroorganizmu, zpusob prípravy farmaceutického prostredku, zpusob identifikace slouceniny a zpusob príprav
CN1912141B (zh) * 1994-12-09 2010-10-27 紧急产品开发英国有限公司 基因的鉴定
SG165157A1 (en) * 1994-12-09 2010-10-28 Emergent Product Dev Uk Ltd Identification of genes
US6984490B1 (en) 1994-12-09 2006-01-10 Imperial College Innovations Limited Identification of genes
US5876931A (en) * 1994-12-09 1999-03-02 Rpms Technology Limited Identification of genes
AU711524B2 (en) * 1994-12-09 1999-10-14 Emergent Product Development Uk Limited Identification of genes
US6015669A (en) * 1994-12-09 2000-01-18 Imperial College Innovations Limited Identification of genes
US7842290B2 (en) 1994-12-09 2010-11-30 Emergent Product Development Uk Limited Identification of genes
AU711524C (en) * 1994-12-09 2004-03-18 Emergent Product Development Uk Limited Identification of genes
EP1538222A1 (fr) * 1995-01-16 2005-06-08 Institut Pasteur Oligonucléotides pour la détection de salmonella
US6080545A (en) * 1995-01-16 2000-06-27 Institut Pasteur Oligonucleotides for the detection of salmonella
US5824795A (en) * 1995-01-16 1998-10-20 Institut Pasteur Oligonucleotides for the detection of salmonella
FR2729392A1 (fr) * 1995-01-16 1996-07-19 Pasteur Institut Oligonucleotides pour la detection de salmonella
EP0721989A1 (fr) * 1995-01-16 1996-07-17 Institut Pasteur Oligonucléotides pour la détection de salmonella
EP0739987A3 (fr) * 1995-04-28 1998-07-29 Shimadzu Corporation Oligonucléotides et procédé pour le dépistage de Salmonella
US5846783A (en) * 1996-01-16 1998-12-08 Gull Laboratories Methods and apparatus for preparing, amplifying, and discriminating multiple analytes
WO2000002913A1 (fr) * 1998-07-10 2000-01-20 Jari Pharmaceuticals B.V. Proteine du staphylocoque inhibitrice de chimiotactisme et son utilisation
US7955600B2 (en) 1998-09-04 2011-06-07 Emergent Product Development Uk Limited Attenuated salmonella SP12 mutants as antigen carriers
US7700104B2 (en) 1998-09-04 2010-04-20 Emergent Product Development Uk Limited Attenuated Salmonella SP12 mutants as antigen carriers
US6936425B1 (en) 1998-09-04 2005-08-30 Microscience Limited Attenuated salmonella SP12 mutants as antigen carriers
US7887816B2 (en) 1999-05-10 2011-02-15 Emergent Product Development Uk Limited Attenuated microorganisms for the treatment of infection
US7081513B2 (en) 2000-01-07 2006-07-25 Alligator Bioscience Ab Nucleic acids encoding (poly) peptides having chips activity
US7388078B2 (en) 2000-01-07 2008-06-17 Alligator Bioscience Ab Nucleic acids encoding polypeptides having chips activity
FR2809105A1 (fr) * 2000-05-18 2001-11-23 Becton Dickinson Co Amorces d'amplification modifiees et leurs utilisations
ES2223216B1 (es) * 2002-03-11 2006-04-16 Universidad De Sevilla Metodo para la deteccion e identificacion rapida de salmonella spp. mediante la reaccion en cadena de la polimerasa en tiempo real.
ES2223216A1 (es) * 2002-03-11 2005-02-16 Universidad De Sevilla Metodo para la deteccion e identificacion rapida de bacterias patogenas transmisibles por alimentos mediante la reaccion en cadena de la polimerasa en tiempo real.
WO2003076641A3 (fr) * 2002-03-11 2003-12-04 Univ Sevilla Procede de detection et d'identification rapide de bacteries pathogenes transmissibles par des aliments au moyen de l'amplification en chaine par polymerase en temps reel
US11920139B2 (en) 2007-05-10 2024-03-05 The Washington University Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
US8445254B2 (en) 2007-05-10 2013-05-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
US9297015B2 (en) 2007-05-10 2016-03-29 Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
US11180765B2 (en) 2007-05-10 2021-11-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
US10774334B2 (en) 2007-05-10 2020-09-15 Arizona Broad of Regents on Behalf of Arizona State University Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
US8465755B2 (en) 2007-10-05 2013-06-18 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
US9040059B2 (en) 2007-10-05 2015-05-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting a protective immune response against C. perfringens
EP2284283A4 (fr) * 2008-04-30 2011-10-05 Univ Pais Vasco Procédés et réactifs pour la détection de salmonella sp.
EP2284283A1 (fr) * 2008-04-30 2011-02-16 Universidad del Pais Vasco Procédés et réactifs pour la détection de salmonella sp.
US9050285B2 (en) 2008-10-17 2015-06-09 The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
US9481888B2 (en) 2009-05-22 2016-11-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
US8889121B2 (en) 2010-01-22 2014-11-18 The Arizona Board Of Regents For An On Behalf Of Arizona State University Bacterium comprising a regulated rfaH nucleic acid
KR101793682B1 (ko) * 2010-03-11 2017-11-03 한화테크윈 주식회사 절단 가능한 키메릭 프로브를 사용한 살모넬라의 실시간 검출 방법
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof

Also Published As

Publication number Publication date
EP0669989A1 (fr) 1995-09-06
EP0669989A4 (fr) 1994-12-20
AU2509592A (en) 1993-03-16

Similar Documents

Publication Publication Date Title
WO1993004202A1 (fr) Sondes de polynucleotide de detection de salmonelle
JPH11503921A (ja) 種の同定のための普遍的標的
EP0581171A1 (fr) Oligonucléotides spécifiques des espèces des bifidobactéries et procédé de détection les utilisant
US5652102A (en) Assay for enterohemorrhagic Escherichia coli 0157:H7 by the polymerase chain reaction
US5958686A (en) Simple PCR technique for detecting and differentiating bacterial pathogens
JP2695127B2 (ja) ミコバクテリウムカンサシに特異的な核酸配列
US5786147A (en) Detection of enterobacteria
JP2792462B2 (ja) サルモネラ属菌検出のためのオリゴヌクレオチドおよびそれを用いた検出法
US6391631B1 (en) Bacterial plasmids
EP0554437B1 (fr) Sondes d'acide nucleique utilisees dans la detection de shigella
US6489107B1 (en) Method for identifying Escherichia coli strain DSM 6601
JP2001512665A (ja) 大腸菌種に特異的なオリゴヌクレオチド並びにその種の細菌の検出および視覚化法
JPH10210980A (ja) 乳酸菌検出用オリゴヌクレオチド及び該菌の検出方法
JP3107904B2 (ja) ラクトバチルス属細菌の検出方法
JP4037926B2 (ja) Ｓ．ｄｉａｓｔａｔｉｃｕｓの検出に用いるプライマー
JPH06253847A (ja) 炭疽菌検出のためのオリゴヌクレオチドおよびそれを用いた検出方法
US20060110729A1 (en) Method of dna testing for mycobacterium paratuberculosis strains
JP3067850B2 (ja) オリゴヌクレオチド及びそれを用いた乳酸菌の検出法
EP1321530B1 (fr) Méthode pour détecter Escherichia coli
JP2001516590A (ja) ストレプトマイセテスとマデュロマイセテスとを識別するハイブリダイゼーションプローブ
JPH06261759A (ja) 炭疽菌検出のためのオリゴヌクレオチドおよびそれを用いた検出方法
JPH04293486A (ja) 細菌検出のためのオリゴヌクレオチドおよびそれを用いた検出法
JP2005006557A (ja) Ｐｃｒによるビール有害乳酸菌の同定法
JP3331977B2 (ja) 赤痢菌検出のためのオリゴヌクレオチドおよびそれを用いた検出法
JPH11332600A (ja) 病原性大腸菌ｏ１５７検出のためのオリゴヌクレオチドおよびそれを用いた検出法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992918989

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWP Wipo information: published in national office

Ref document number: 1992918989

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992918989

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载